Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Boat builders' occupational contact dermatitis - 11-year data from the Finnish register of occupational diseases.

Aalto-Korte K, Koskela K, Pesonen M.

Contact Dermatitis. 2018 May;78(5):370-371. doi: 10.1111/cod.12965. Epub 2018 Jan 31. No abstract available.

PMID:
29383726
2.

Phylogeographic separation and formation of sexually discrete lineages in a global population of Yersinia pseudotuberculosis.

Seecharran T, Kalin-Manttari L, Koskela K, Nikkari S, Dickins B, Corander J, Skurnik M, McNally A.

Microb Genom. 2017 Sep 18;3(10):e000133. doi: 10.1099/mgen.0.000133. eCollection 2017 Oct.

3.

Radial Dopant Placement for Tuning Plasmonic Properties in Metal Oxide Nanocrystals.

Crockett BM, Jansons AW, Koskela KM, Johnson DW, Hutchison JE.

ACS Nano. 2017 Aug 22;11(8):7719-7728. doi: 10.1021/acsnano.7b01053. Epub 2017 Jul 18.

PMID:
28718619
4.

Effects of growth and aging on the reference values of pulmonary nitric oxide dynamics in healthy subjects.

Högman M, Thornadtsson A, Liv P, Hua-Huy T, Dinh-Xuan AT, Tufvesson E, Dressel H, Janson C, Koskela K, Oksa P, Sauni R, Uitti J, Moilanen E, Lehtimäki L.

J Breath Res. 2017 Sep 13;11(4):047103. doi: 10.1088/1752-7163/aa7957.

5.

Hypofractionated stereotactic body radiotherapy for localized prostate cancer - first Nordic clinical experience.

Koskela K, Palmgren JE, Heikkilä J, Virsunen H, Sailas L, Auvinen P, Seppälä J, Kataja V.

Acta Oncol. 2017 Jul;56(7):978-983. doi: 10.1080/0284186X.2017.1288923. Epub 2017 Feb 26.

PMID:
28514930
6.

Metagenomic Evaluation of Bacteria from Voles.

Koskela KA, Kalin-Mänttäri L, Hemmilä H, Smura T, Kinnunen PM, Niemimaa J, Henttonen H, Nikkari S.

Vector Borne Zoonotic Dis. 2017 Feb;17(2):123-133. doi: 10.1089/vbz.2016.1969. Epub 2016 Nov 17.

PMID:
27854567
7.

Flattening filter free technique in breath-hold treatments of left-sided breast cancer: The effect on beam-on time and dose distributions.

Koivumäki T, Heikkilä J, Väänänen A, Koskela K, Sillanmäki S, Seppälä J.

Radiother Oncol. 2016 Jan;118(1):194-8. doi: 10.1016/j.radonc.2015.11.032. Epub 2015 Dec 18.

PMID:
26709069
8.

Volumetric modulated arc therapy for synchronous bilateral whole breast irradiation - A case study.

Seppälä J, Heikkilä J, Myllyoja K, Koskela K.

Rep Pract Oncol Radiother. 2015 Sep-Oct;20(5):398-402. doi: 10.1016/j.rpor.2015.05.011. Epub 2015 Jun 15.

9.

Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy.

Virén T, Heikkilä J, Myllyoja K, Koskela K, Lahtinen T, Seppälä J.

Radiat Oncol. 2015 Apr 8;10:79. doi: 10.1186/s13014-015-0392-x.

10.

Generation of a CRISPR database for Yersinia pseudotuberculosis complex and role of CRISPR-based immunity in conjugation.

Koskela KA, Mattinen L, Kalin-Mänttäri L, Vergnaud G, Gorgé O, Nikkari S, Skurnik M.

Environ Microbiol. 2015 Nov;17(11):4306-21. doi: 10.1111/1462-2920.12816. Epub 2015 Mar 27.

11.

Pulmonary inflammation in foundry workers.

Koskela K, Oksa P, Sauni R, Linnainmaa M, Toivio P, Lehtimäki L, Moilanen E, Nieminen R, Luukkonen R, Uitti J.

J Occup Environ Med. 2015 Feb;57(2):124-8. doi: 10.1097/JOM.0000000000000390.

PMID:
25654513
12.

The role of microbes in the pathogenesis of acute rhinosinusitis in young adults.

Autio TJ, Tapiainen T, Koskenkorva T, Närkiö M, Lappalainen M, Nikkari S, Hemmilä H, Koskela KA, Koskela M, Koivunen P, Alho OP.

Laryngoscope. 2015 Jan;125(1):E1-7. doi: 10.1002/lary.24862. Epub 2014 Aug 5.

PMID:
25093843
13.

Detection of Francisella tularensis in voles in Finland.

Rossow H, Sissonen S, Koskela KA, Kinnunen PM, Hemmilä H, Niemimaa J, Huitu O, Kuusi M, Vapalahti O, Henttonen H, Nikkari S.

Vector Borne Zoonotic Dis. 2014 Mar;14(3):193-8. doi: 10.1089/vbz.2012.1255. Epub 2014 Feb 27.

14.

Bacterial DNA signatures in carotid atherosclerosis represent both commensals and pathogens of skin origin.

Renko J, Koskela KA, Lepp PW, Oksala N, Levula M, Lehtimäki T, Solakivi T, Kunnas T, Nikkari S, Nikkari ST.

Eur J Dermatol. 2013 Jan-Feb;23(1):53-8. doi: 10.1684/ejd.2012.1908.

PMID:
23406581
15.

Detection of influenza A viruses with a portable real-time PCR instrument.

Mölsä M, Koskela KA, Rönkkö E, Ikonen N, Ziegler T, Nikkari S.

J Virol Methods. 2012 May;181(2):188-91. doi: 10.1016/j.jviromet.2012.02.001. Epub 2012 Feb 22.

PMID:
22374102
16.

A multiplatform real-time polymerase chain reaction detection assay for Vibrio cholerae.

Koskela KA, Matero P, Blatny JM, Fykse EM, Olsen JS, Nuotio LO, Nikkari S.

Diagn Microbiol Infect Dis. 2009 Nov;65(3):339-44. doi: 10.1016/j.diagmicrobio.2009.07.009. Epub 2009 Sep 2.

PMID:
19729262
17.

Asthma Programme in Finland: high consensus between general practitioners and pulmonologists on the contents of an asthma referral letter.

Tuomisto L, Erhola M, Kaila M, Brander PE, Puolijoki H, Kauppinen R, Koskela K.

Prim Care Respir J. 2004 Dec;13(4):205-10.

18.

Loss of Pax5 promotes plasma cell differentiation.

Nera KP, Kohonen P, Narvi E, Peippo A, Mustonen L, Terho P, Koskela K, Buerstedde JM, Lassila O.

Immunity. 2006 Mar;24(3):283-93.

19.

Development of early PCLP1-expressing haematopoietic cells within the avian dorsal aorta.

Suonpää P, Kohonen P, Koskela K, Koskiniemi H, Salminen-Mankonen H, Lassila O.

Scand J Immunol. 2005 Sep;62(3):218-23.

20.

Thalidomide therapy and polyneuropathy in myeloma patients.

Laaksonen S, Remes K, Koskela K, Voipio-Pulkki LM, Falck B.

Electromyogr Clin Neurophysiol. 2005 Mar;45(2):75-86.

PMID:
15861857
21.

Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial.

Koskela K, Pelliniemi TT, Pulkki K, Remes K.

Leuk Lymphoma. 2004 Apr;45(4):749-54.

PMID:
15160951
22.

Chicken B-cell-activating factor: regulator of B-cell survival in the bursa of fabricius.

Koskela K, Nieminen P, Kohonen P, Salminen H, Lassila O.

Scand J Immunol. 2004 May;59(5):449-57.

23.

Use of alternative drugs in Finland.

Mäntyranta T, Hemminki E, Koskela K.

Pharmacoepidemiol Drug Saf. 1999 Jan;8(1):23-9.

PMID:
15073943
24.

Identification of a novel cytokine-like transcript differentially expressed in avian gammadelta T cells.

Koskela K, Kohonen P, Salminen H, Uchida T, Buerstedde JM, Lassila O.

Immunogenetics. 2004 Mar;55(12):845-54. Epub 2004 Feb 4.

PMID:
14760511
25.

Insight into lymphoid development by gene expression profiling of avian B cells.

Koskela K, Kohonen P, Nieminen P, Buerstedde JM, Lassila O.

Immunogenetics. 2003 Sep;55(6):412-22. Epub 2003 Aug 21.

PMID:
12937956
26.

The asthma programme of Finland: an evaluation survey in primary health care.

Erhola M, Mäkinen R, Koskela K, Bergman V, Klaukka T, Mäkelä M, Tirkkonen L, Kaila M.

Int J Tuberc Lung Dis. 2003 Jun;7(6):592-8.

PMID:
12797704
27.

Sleep apnoea: Finnish National guidelines for prevention and treatment 2002-2012.

Laitinen LA, Anttalainen U, Pietinalho A, Hämäläinen P, Koskela K; Expert Advisory Group Listed in Foreword.

Respir Med. 2003 Apr;97(4):337-65.

28.
29.

[Why did a young man get a recurrent pulmonary embolism?].

Hietarinta M, Itälä M, Kauppila M, Koskela K.

Duodecim. 2001;117(6):578-80. Finnish. No abstract available.

PMID:
12116490
30.

The quality of spirometric examinations in Finland: results from a national questionnaire survey.

Piirilä P, Pietinalho A, Loponen M, Naumanen H, Nurminen M, Siukola A, Korhonen O, Koskela K, Sovijärvi A.

Clin Physiol Funct Imaging. 2002 May;22(3):233-9.

PMID:
12076352
31.

Implementation of the DOTS strategy for tuberculosis in the Leningrad Region, Russian Federation (1998-1999).

Ruohonen RP, Goloubeva TM, Trnka L, Fomin MM, Zhemkova GA, Sinitsyn AV, Lichachev AA, Koskela KG.

Int J Tuberc Lung Dis. 2002 Mar;6(3):192-7.

PMID:
11934136
32.

Autocrine production and synergistic growth-promoting activity of interleukin-6 and oncostatin M in a new human myeloma cell line TU-1.

Koskela K, Pelliniemi TT, Pelliniemi LJ, Remes K, Södeström KO, Punnonen K, Kumar R, Ollikainen H, Pulkki K.

Acta Haematol. 2002;107(1):23-8.

PMID:
11818668
33.

Asthma programme in Finland: a community problem needs community solutions.

Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA; Working Group of the Asthma Programme in Finland 1994-2004.

Thorax. 2001 Oct;56(10):806-14. No abstract available.

34.

Men, women and friends--are there differences in relation to mental well-being?

Hintikka J, Koskela T, Kontula O, Koskela K, Viinamäki H.

Qual Life Res. 2000;9(7):841-5.

PMID:
11297026
36.

Gender differences in associations between religious attendance and mental health in Finland.

Hintikka J, Koskela K, Kontula O, Viinamäki H.

J Nerv Ment Dis. 2000 Nov;188(11):772-6.

PMID:
11093380
37.

The Ikaros family and the development of early intraembryonic hematopoietic stem cells.

Liippo J, Nera KP, Kohonen P, Lampisuo M, Koskela K, Nieminen P, Lassila O.

Curr Top Microbiol Immunol. 2000;251:51-8. No abstract available.

PMID:
11036758
38.

Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis.

Koskela K, Pelliniemi TT, Rajamäki A, Pulkki K, Remes K.

Eur J Haematol. 2000 Jul;65(1):52-6.

PMID:
10914939
39.

Increase in the prevalence of common mental disorders during an upswing in the national economy.

Hintikka J, Kontula O, Niskanen L, Koskela K, Viinamäki H.

Scand J Public Health. 2000 Mar;28(1):79-80. No abstract available.

PMID:
10817319
40.

Common mental disorders, suicidality and use of health care services during late adolescence in Finland.

Hintikka J, Hintikka U, Koskela K, Kontula O.

J Adolesc Health. 2000 Jan;26(1):2-3. No abstract available.

PMID:
10638711
41.

Does regular attendance at sporting events promote mental health?

Hintikka J, Viinamäki H, Koskela K, Kontula O.

Can J Psychiatry. 1999 Aug;44(6):608. No abstract available.

PMID:
10497710
43.

Debt and suicidal behaviour in the Finnish general population.

Hintikka J, Kontula O, Saarinen P, Tanskanen A, Koskela K, Viinamäki H.

Acta Psychiatr Scand. 1998 Dec;98(6):493-6.

PMID:
9879793
44.

Costimulatory function of CD28 in avian gammadelta T cells is evolutionarily conserved.

Koskela K, Arstila TP, Lassila O.

Scand J Immunol. 1998 Dec;48(6):635-41.

45.

Suicidal ideation and parasuicide in the Finnish general population.

Hintikka J, Viinamäki H, Tanskanen A, Kontula O, Koskela K.

Acta Psychiatr Scand. 1998 Jul;98(1):23-7.

PMID:
9696510
46.

Plasma cell leukemia 3 months after autologous blood cell transplantation for multiple myeloma.

Koskela K, Pelliniemi TT, Lakkala T, Remes K.

Bone Marrow Transplant. 1998 Feb;21(3):305-7.

47.

p53 gene mutations are rare in patients but common in patient-originating cell lines in multiple myeloma.

Ollikainen H, Syrjänen S, Koskela K, Pelliniemi TT, Pulkki K.

Scand J Clin Lab Invest. 1997 Jul;57(4):281-9.

PMID:
9249875
48.

Serum oncostatin M in multiple myeloma: association with prognostic factors.

Koskela K, Pelliniemi TT, Remes K, Rajamäki A, Pulkki K.

Br J Haematol. 1997 Jan;96(1):158-60.

PMID:
9012701
49.

Smart Habit Xylitol campaign, a new approach in oral health promotion.

Nordblad A, Suominen-Taipale L, Murtomaa H, Vartiainen E, Koskela K.

Community Dent Health. 1995 Dec;12(4):230-4.

PMID:
8536087
50.

The association between economic and social factors and mental health in Finland.

Viinamäki H, Kontula O, Niskanen L, Koskela K.

Acta Psychiatr Scand. 1995 Sep;92(3):208-13.

PMID:
7484200

Supplemental Content

Loading ...
Support Center